NEW YORK – Vaccinated monkeys have developed “long-term” immunity to the Ebola virus, raising a prospect of successful human trials, say scientists. The experiments by the US National Institutes of Health showed immunity could last at least 10 months. Human trials of the vaccine started this week in the US and will extend to the…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions